Back

Zalunfiban: is it really time to CELEBRATE?

29 August 2026 (08:33 - 08:51)
Organised by: Logo
Congress Presentation Part of: Novel antithrombotic approaches in acute coronary syndromes Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Arnoud W J van 't Hof

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Unfractionated heparin in the field
Doctor J. Chen (Wuhan, CN)
Slides Video
Presentation thumbnail
Is there a role for prasugrel monotherapy?
Doctor P. Guimaraes (Sao Paulo, BR)
Slides Video
Presentation thumbnail
Any hope for factor XI inhibition?
Doctor J. Ferreiro (Tarragona, ES)
Slides Video
Presentation thumbnail
Novel antithrombotic approaches in acute coronary syndromes - discussion
Video

Access the full session

Session thumbnail
Novel antithrombotic approaches in acute coronary syndromes
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 08:33 CET
You may be interested in
thumbnail
Congress Presentation
Pre-hospital zalunfiban improves ST resolution before angiography in patients with STEMI
20 March 2026
thumbnail
Congress Session
Problem-solving in antiplatelet therapy and anticoagulation
26 August 2022
thumbnail
Congress Presentation
The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocardial infarction
18 March 2022
thumbnail
Congress Session
Top 10 papers 2025 in prevention, ischaemic heart disease, and interventional cardiology
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources